133 related articles for article (PubMed ID: 30465500)
1. Three-Dimensional Manufactured Supports for Breast Cancer Stem Cell Population Characterization.
Polonio-Alcalá E; Rabionet M; Ruiz-Martínez S; Ciurana J; Puig T
Curr Drug Targets; 2019; 20(8):839-851. PubMed ID: 30465500
[TBL] [Abstract][Full Text] [Related]
2. Screening of Additive Manufactured Scaffolds Designs for Triple Negative Breast Cancer 3D Cell Culture and Stem-Like Expansion.
Polonio-Alcalá E; Rabionet M; Guerra AJ; Yeste M; Ciurana J; Puig T
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322103
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional tissue culture model of human breast cancer for the evaluation of multidrug resistance.
Ding Y; Liu W; Yu W; Lu S; Liu M; Kaplan DL; Wang X
J Tissue Eng Regen Med; 2018 Sep; 12(9):1959-1971. PubMed ID: 30055109
[TBL] [Abstract][Full Text] [Related]
5. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Stem Cell Culture and Enrichment Using Poly(ε-Caprolactone) Scaffolds.
Palomeras S; Rabionet M; Ferrer I; Sarrats A; Garcia-Romeu ML; Puig T; Ciurana J
Molecules; 2016 Apr; 21(4):537. PubMed ID: 27120585
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological targets of breast cancer stem cells: a review.
Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK
Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):463-479. PubMed ID: 29476201
[TBL] [Abstract][Full Text] [Related]
8. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
Sousa B; Ribeiro AS; Paredes J
Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
[TBL] [Abstract][Full Text] [Related]
10. Electrospun nanofiber scaffolds for the propagation and analysis of breast cancer stem cells in vitro.
Prieto EI; Mojares EBA; Cortez JJM; Vasquez MR
Biomed Mater; 2021 Feb; 16(3):035004. PubMed ID: 33634797
[TBL] [Abstract][Full Text] [Related]
11. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis.
Nogueras Pérez R; Heredia-Nicolás N; de Lara-Peña L; López de Andrés J; Marchal JA; Jiménez G; Griñán-Lisón C
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958993
[TBL] [Abstract][Full Text] [Related]
13. Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
Das T; Nair RR; Green R; Padhee S; Howell M; Banerjee J; Mohapatra SS; Mohapatra S
Anticancer Res; 2017 Apr; 37(4):1655-1663. PubMed ID: 28373426
[TBL] [Abstract][Full Text] [Related]
14. Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis.
Angeloni V; Contessi N; De Marco C; Bertoldi S; Tanzi MC; Daidone MG; Farè S
Acta Biomater; 2017 Nov; 63():306-316. PubMed ID: 28927931
[TBL] [Abstract][Full Text] [Related]
15. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
16. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
[TBL] [Abstract][Full Text] [Related]
17. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
Chiotaki R; Polioudaki H; Theodoropoulos PA
Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
